Efficacy and safety of direct oral anticoagulants in patients undergoing elective electrical cardioversion: A real-world patient population-Reference-Cited by-同舟云学术

Efficacy and safety of direct oral anticoagulants in patients undergoing elective electrical cardioversion: A real-world patient population

Published:2021-03 Issue: Volume:326 Page:98-102
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

de Heide John,de Wit André,Bhagwandien Rohit E.,Assaf Amira,Gros-Bisdom Jaleesa,van der Meer Koen C.,Wijchers Sip A.,Zijlstra Felix,Szili-Torok Tamas,Lenzen Mattie J.,Yap Sing-Chien

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference30 articles.

1. The 2018 European heart rhythm association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation;Steffel;Eur. Heart J.,2018

2. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS;Kirchhof;Eur. Heart J.,2016

3. Efficacy and safety of apixaban in patients after cardioversion for atrial fibrillation: insights from the ARISTOTLE trial (Apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation);Flaker;J. Am. Coll. Cardiol.,2014

4. Dabigatran versus warfarin in patients with atrial fibrillation: an analysis of patients undergoing cardioversion;Nagarakanti;Circulation.,2011

5. Outcomes after cardioversion and atrial fibrillation ablation in patients treated with rivaroxaban and warfarin in the ROCKET AF trial;Piccini;J. Am. Coll. Cardiol.,2013

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Elective Direct Current Cardioversion of Atrial Fibrillation: Silent Brain Infarction and Health-Related Quality of Life;Cardiology;2024-08-01

2. Safety and efficacy of direct oral anticoagulants versus vitamin K antagonists in atrial fibrillation electrical cardioversion: An update systematic review and meta-analysis;International Journal of Cardiology;2023-05

3. Experience with Apixaban Versus Acenocumarol in Usual Clinical Practice in Patients with Persistent Non-Valvular Atrial Fibrillation Treated with Electric Cardioversion Ambulatory;2022-11-03

4. Anticoagulation after cardioversion of atrial fibrillation: What if we could stop earlier than 4 weeks?;International Journal of Cardiology;2022-04

5. Trends and Outcomes of Oral Anticoagulation With Direct Current Cardioversion for Atrial Fibrillation/Flutter at an Academic Medical Center;Cardiology Research;2022-04